Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) ...

Before we head out for the holidays, we're back with some breaking news about a few of BIO's legislative priorities. Happy Holidays and Happy New Year! We'll see you in 2025 (unless there's major ...

BIO’s new and improved partnering system – BIO Partnering – is debuting at the 2025 BIO CEO & Investor Conference (Feb 10-11 in New York, NY). Join BIO’s VP of Partnering, Mackensie Vernetti, for a ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a ...

Commercialization Readiness from Preclinical to 1st Launch: The First Time CEOs Playbook will equip early-stage biotechnology leaders with the commercialization knowledge they need to strategically ...

Today, the Biotechnology Innovation Organization (BIO) named Sarah Alspach as its new executive vice president and chief communications officer. Alspach, a communications veteran, will join BIO’s ...

A busy Monday brings louder calls for PBM reform, plus a report on U.S. biotech economic output and jobs, news on avian flu and plant biotech regulations, and more. (834 words, 4 minutes, 10 seconds) ...

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic ...

Hope you enjoyed the holiday weekend. We’re back with BIO’s Bio.News series on the problems with PBMs, plus a recap of BIO’s IP Counsels Committee Conference and more news you need to know. (573 words ...